In fact, companies like Pfizer and Amgen recently have spent more money in buying back their shares to boost their stock price than on R&amp;D, but that's a whole different TED Talk which one day I'd be fascinated to tell you about.
De hecho, empresas como  Pfizer y Amgen recientemente gastaron mucho más dinero  recomprando sus acciones para subirles el precio,  que en I+D, pero esa es una  charla TED que otro día me fascinaría dar.